Effects of exercise performance on drugs used in musculoskeletal disorders.
Non-steroidal analgesic and anti-inflammatory drugs (NSAID) are potent inhibitors of prostaglandin synthesis in vivo at commonly achieved concentrations of these drugs. Prostaglandins of the E-series are released by exercising muscles, and their release is inhibited by indomethacin. The consequences, with respect to exercise performance, are unknown. Drugs used for hyperuricemia and gout such as colchicine, allopurinol, probenecid, and sulphinpyrazone have not been implicated in affecting exercise performance. The uricosuric drugs probenecid and sulphinpyrazone may be contraindicated in individuals who exercise heavily because of the increased danger of precipitating uric acid crystals in the kidney tubules. Muscle relaxants do not cause measurable muscle relaxation following usual oral dosage regimens. They are, however, sedatives and this property could influence exercise performance.
D000493:Allopurinol / Q000627:therapeutic use; D000700:Analgesics / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001847:Bone Diseases / Q000188:drug therapy*; D003078:Colchicine / Q000627:therapeutic use; D006073:Gout / Q000188:drug therapy; D006801:Humans; D009125:Muscle Relaxants, Central / Q000627:therapeutic use; D009135:Muscular Diseases / Q000188:drug therapy*; D005082:Physical Exertion; D011339:Probenecid / Q000627:therapeutic use; D011453:Prostaglandins / Q000096:biosynthesis; D014527:Uric Acid / Q000097:blood
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D009125:Muscle Relaxants, Central; D011453:Prostaglandins; D014527:Uric Acid; D000493:Allopurinol; D011339:Probenecid; D003078:Colchicine